Patent Application
20150275236
1. Field of the Invention
The present invention relates to a method of manufacturing 1,4-butanediol and a microbe.
2. Description of the Related Art
In recent years, attention is paid to a compound manufacturing process with a renewable source as a raw material from the viewpoint of depletion of fossil resource, a countermeasure for global warming, or the like. In particular, a so-called bio-refinery has widely been studied wherein a variety of compounds as raw materials for a polymer or compounds as raw materials for a chemical product are manufactured in biochemical processes with biomass as raw materials.
For compounds that are expected as raw material conversion of biomass, 1,4-butanediol may be used. 1,4-butanediol is widely used as a synthetic raw material for a fine organic chemical product, a monomer unit of a polyester and an engineering plastic or the like, and its market scale is large. Thus, demand for a method of efficiently manufacturing 1,4-butanediol is becoming large in a biochemical process with a renewable source such as biomass or the like as a raw material.
For methods of manufacturing 1,4-butanediol using a biochemical process, for example, methods disclosed in Patent documents 1 and 2 and Non-patent document 1 may be used.
However, the methods disclosed in Patent documents 1 and 2 and Non-patent document 1 are complicated processes.
For a problem as described above, there is provided a new method of manufacturing 1,4-butanediol capable of economically obtaining 1,4-butanediol.
The present invention includes the following.
[1] A method of manufacturing 1,4-butanediol, using a microbe and/or a culture thereof, by an enzyme reaction system that uses acetoacetyl-CoA reductase and enoyl-CoA hydratase, via acetoacetyl-CoA, 3-hydroxybutyryl-CoA and crotonyl-CoA in this order, wherein each of the acetoacetyl-CoA reductase and the enoyl-CoA hydratase is specific to a stereoisomer of 3-hydroxybutyryl-CoA.
[2] The method of manufacturing 1,4-butanediol according to [1],
wherein the acetoacetyl-CoA reductase is (S)-3-hydroxybutyryl-CoA selective acetoacetyl-CoA reductase and the enoyl CoA reductase is (S)-3-hydroxybutyryl-CoA selective enoyl-CoA hydratase, and
wherein the microbe includes
(1) a gene that codes the (S)-3-hydroxybutyryl-CoA selective acetoacetyl-CoA reductase, and
(2) a gene that codes the (S)-3-hydroxybutyryl-CoA selective enoyl-CoA hydratase.
[3] The method of manufacturing 1,4-butanediol according to [2],
wherein the (S)-3-hydroxybutyryl-CoA selective acetoacetyl-CoA reductase is 3-hydroxybutyryl-CoA dehydrogenase (EC number: 1.1.1.35) or 3-hydroxyacyl CoA dehydrogenase (EC number: 1.1.1.157), and
wherein the (S)-3-hydroxybutyryl-CoA selective enoyl-CoA hydratase is enoyl-CoA hydratase (EC number: 4.2.1.17).
[4] The method of manufacturing 1,4-butanediol according to [2],
wherein a gene that codes the (S)-3-hydroxybutyryl-CoA selective acetoacetyl-CoA reductase is any one of undermentioned genes (a) to (c), and
wherein a gene that codes the (S)-3-hydroxybutyryl-CoA selective enoyl-CoA hydratase is any one of undermentioned genes (d) to (f):
(a) a gene that has a base sequence of sequence number 2;
(b) a gene that has a base sequence such that one or more bases are deleted, substituted, or added in a base sequence of sequence number 2, wherein the gene has a base sequence with an identity greater than or equal to 90% with respect to the base sequence of sequence number 2;
(c) a gene that hybridizes with a gene that has a base sequence complementary with a gene that has a base sequence described in sequence number 2 on a stringent condition;
(d) a gene that has a base sequence of sequence number 4;
(e) a gene that has a base sequence such that one or more bases are deleted, substituted, or added in a base sequence of sequence number 4, wherein the gene has a base sequence with an identity greater than or equal to 90% with respect to the base sequence of sequence number 4;
(f) a gene that hybridizes with a gene that has a base sequence complementary with a gene that has a base sequence described in sequence number 4 on a stringent condition.
[5] The method of manufacturing 1,4-butanediol according to [1],
wherein the acetoacetyl-CoA reductase is (R)-3-hydroxybutyryl-CoA selective acetoacetyl-CoA reductase and the enoyl CoA reductase is (R)-3-hydroxybutyryl-CoA selective enoyl-CoA hydratase, and
wherein the microbe includes
(1) a gene that codes the (R)-3-hydroxybutyryl-CoA selective acetoacetyl-CoA reductase, and
(2) a gene that codes the (R)-3-hydroxybutyryl-CoA selective enoyl-CoA hydratase.
[6] The method of manufacturing 1,4-butanediol according to [5],
wherein the (R)-3-hydroxybutyryl-CoA selective acetoacetyl-CoA reductase is acetoacetyl-CoA reductase (EC number: 1.1.1.36), and
wherein the (R)-3-hydroxybutyryl-CoA selective enoyl-CoA hydratase is enoyl-CoA hydratase (EC number: 4.2.1.55 or EC number: 4.2.1.119).
[7] The method of manufacturing 1,4-butanediol according to [5],
wherein a gene that codes the (R)-3-hydroxybutyryl-CoA selective acetoacetyl-CoA reductase is any one of undermentioned genes (a) to (c), and
wherein a gene that codes the (R)-3-hydroxybutyryl-CoA selective enoyl-CoA hydratase is any one of undermentioned genes (d) to (f):
(a) a gene that has a base sequence of sequence number 3;
(b) a gene that has a base sequence such that one or more bases are deleted, substituted, or added in a base sequence of sequence number 3, wherein the gene has a base sequence with an identity greater than or equal to 90% with respect to the base sequence of sequence number 3;
(c) a gene that hybridizes with a gene that has a base sequence complementary with a gene that has a base sequence described in sequence number 3 on a stringent condition;
(d) a gene that has a base sequence of sequence number 5;
(e) a gene that has a base sequence such that one or more bases are deleted, substituted, or added in a base sequence of sequence number 5, wherein the gene has a base sequence with an identity greater than or equal to 90% with respect to the base sequence of sequence number 5;
(f) a gene that hybridizes with a gene that has a base sequence complementary with a gene that has a base sequence described in sequence number 5 on a stringent condition.
[8] The method of manufacturing 1,4-butanediol according to [1], wherein the microbe further includes,
(1) a gene that codes vinylacetyl-CoA delta-isomerase (EC number: 5.3.3.3),
(2) a gene that codes 4-hydroxybutyryl-CoA dehydratase (EC number: 4.2.1.120), and/or
(3) a gene that codes acyl-CoA reductase (EC number: 1.2.1.10).
[9] The method of manufacturing 1,4-butanediol according to [1],
wherein the microbe is Escherichia coli, a yeast, a corynebacterium or a clostridial bacteria.
[10] A microbe that manufactures 1,4-butanediol by an enzyme reaction system that uses acetoacetyl-CoA reductase and enoyl-CoA hydratase, via acetoacetyl-CoA, 3-hydroxybutyryl-CoA and crotonyl-CoA in this order,
wherein each of the acetoacetyl-CoA reductase and the enoyl-CoA hydratase is specific to a stereoisomer of 3-hydroxybutyryl-CoA.
[11] The microbe according to [10],
wherein the acetoacetyl-CoA reductase is (S)-3-hydroxybutyryl-CoA selective acetoacetyl-CoA reductase and the enoyl CoA reductase is (S)-3-hydroxybutyryl-CoA selective enoyl-CoA hydratase, and
wherein the microbe includes
(1) a gene that codes the (S)-3-hydroxybutyryl-CoA selective acetoacetyl-CoA reductase, and
(2) a gene that codes the (S)-3-hydroxybutyryl-CoA selective enoyl-CoA hydratase.
[12] The microbe according to [10],
wherein the acetoacetyl-CoA reductase is (R)-3-hydroxybutyryl-CoA selective acetoacetyl-CoA reductase and the enoyl CoA reductase is (R)-3-hydroxybutyryl-CoA selective enoyl-CoA hydratase, and
wherein the microbe includes
(1) a gene that codes the (R)-3-hydroxybutyryl-CoA selective acetoacetyl-CoA reductase, and
(2) a gene that codes the (R)-3-hydroxybutyryl-CoA selective enoyl-CoA hydratase.
[13] The microbe according to [10],
wherein the microbe is Escherichia coli, a yeast, a corynebacterium or a clostridial bacteria.
A method of economically manufacturing 1,4-butanediol is provided.
The present invention will be described in detail below. Here, in this specification, “CoA” means “coenzyme A”. Furthermore, “%” indicates “% by mass” unless otherwise described. “ppm” is mass basis.
One of features of the present invention is a method of using a microbe or a culture thereof capable of selectively manufacturing 1,4-butanediol with high productivity. Thus, a microbe that has an enzyme system is used in which 1,4-butanediol is manufactured via acetoacetyl-CoA, 3-hydroxybutyryl-CoA, crotonyl-CoA and 4-hydroxybutyryl-CoA in this order. More specifically, a microbe that has an enzyme system in which 1,4-butanediol is generated via acetoacetyl-CoA, isomerization between 3-hydroxybutyryl-CoA and 4-hydroxy CoA and reduction of 4-hydroxybutyryl-CoA. At this time, specific acetoacetyl-CoA reductase and enoyl-CoA hydratase that are specific to each specific stereoisomer of 3-hydroxybutyryl-CoA are used in combination.
Hereinafter, a feature of a microbe, a method of manufacturing the microbe, a method of using the microbe (in other words, a method of manufacturing 1,4-butanediol), a method of obtaining the manufactured 1,4-butanediol or the like, that is used in this embodiment, is explained.
It is possible to introduce various genes, which will be explained later, to the host microbe used in this embodiment and a gene recombination technique can be applied to the host microbe, for example. Specifically, for example, the host microbe is one capable of being transformed into a microbe in which an enzyme system is added by which 1,4-butanediol is manufactured via acetoacetyl-CoA, 3-hydroxybutyryl-CoA, crotonyl-CoA and 4-hydroxybutyryl-CoA in this order under an appropriate culturing condition, which will be explained later, in addition to an enzyme system that is originally possessed by the host microbe.
In this embodiment, an example of the above mentioned host microbe to which various genes can be introduced is not particularly limited as long as a gene recombination technique can be applied to the host microbe. From the viewpoint of industrial availability, for a specific example, Escherichia coli, a yeast, a coryneform bacteria or a clostridial bacteria may be used. For a yeast, Saccharomyces cerevisiae, Schizosaccharomyces pombe, Kluyveromyces lactis, Kluyveromyces marxianus or the like may be used. For a coryneform bacteria, Corynebacterium glutamicum, Corynebacterium efficiens, Brevibacterium divaricatum, Brevibacterium saccharolyticum, Brevibacterium immariophilum, Brevibacterium lactofermentum, Brevibacterium roseum, Brevibacterium flavum, Brevibacterium thiogenitalis, Corynebacterium acetoacidophilum, Corynebacterium acetoglutamicum, Corynebacterium callunae, Corynebacterium lilium, Corynebacterium mellassecola, Microbacterium ammoniaphilum or the like may be used. For a clostridial bacteria, Clostridium kluyveri, Clostridium acetobutylicum, Clostridium aminobutyricum, Clostridium beijerinckii, Clostridium saccharoperbutylacetonicum or the like may be used. Among these, it is preferable to use Escherichia coli, Saccharomyces cerevisiae, Schizosaccharomyces pombe or Corynebacterium glutamicum, because transformation thereof is easy, and it is more preferable to use Escherichia coli.
Further, the transformation microbe of the embodiment may be used in various embodiments including a cultured microbial cell itself and a culture thereof. The culture of the microbe of the embodiment includes, specifically, a suspended material of a cultured microbial cell by a medium such as a culture medium, buffer or the like, a cell-free extract from a cultured microbial cell, and further a processed material such as a material obtained by condensing, purifying or extracting a component that catalyzes the reaction from the cell-free extract or the like. The culture of the microbe of the embodiment further includes a material in which a processed material of the microbe is immobilized on an insoluble carrier. For such an immobilized carrier, a compound that forms a water-insoluble solid content containing the above described microbial cell or its processed material such as polyacrylamide, polyvinyl alcohol, poly(N-vinylformamide), polyallylamine, polyethyleneimine, methylcellulose, glucomannan, alginate, carrageenan or the like, further, a copolymer or a cross-linked material thereof or the like may be used. A kind of these may be used or a mixture of two or more kinds of these may be used. Further, a material in which the microbe or its extracting solution or extracting component is held on an object previously formed as a solid material such as an activated carbon, porous ceramics, a glass fiber, a porous polymer plastic body, a nitrocellulose film or the like may be used as the culture of the microbe as well.
The host microbe used in this embodiment is a host microbe into which various genes, which will be explained later, can be introduced, and, for example, a gene recombination technique can be applied to the host microbe. Specifically, the transformation microbe further has each enzyme system of an enzyme reaction system by which at least 1,4-butanediol can be manufactured via acetoacetyl-CoA, 3-hydroxybutyryl-CoA, crotonyl-CoA and 4-hydroxybutyryl-CoA in this order, in addition to an enzyme system that is originally possessed by the host microbe. Hereinafter, a gene that codes each enzyme system is explained.
(Gene that Codes (S)-3-Hydroxybutyryl-CoA Selective Acetoacetyl-CoA Reductase or Gene that Codes (R)-3-Hydroxybutyryl-CoA Selective Acetoacetyl-CoA Reductase)
In this specification, a “gene that codes (S)-3-hydroxybutyryl-CoA selective acetoacetyl-CoA reductase” means a gene that codes an enzyme capable of catalyzing a reaction in which acetoacetyl-CoA is reduced as a substrate (or may be an intermediate or a precursor) to generate (S)-3-hydroxybutyryl-CoA. Further, a “gene that codes (R)-3-hydroxybutyryl-CoA selective acetoacetyl-CoA reductase” means a gene that codes an enzyme capable of catalyzing a reaction in which acetoacetyl-CoA is reduced as a substrate (or may be an intermediate or a precursor) to generate (R)-3-hydroxybutyryl-CoA.
For a specific example of the gene that codes the enzyme capable of catalyzing the reaction in which acetoacetyl-CoA is reduced as the substrate (or may be the intermediate or the precursor) to generate (S)-3-hydroxybutyryl-CoA, although not particularly limited, a gene, a homolog thereof or the like that codes 3-hydroxybutyryl-CoA dehydrogenase (EC number: 1.1.1.35) or 3-hydroxyacyl CoA dehydrogenase (EC number: 1.1.1.157) may be used.
Further, for a specific example of the gene that codes the enzyme ((R)-3-hydroxybutyryl-CoA reductase) capable of catalyzing the reaction in which acetoacetyl-CoA is reduced as the substrate (or may be the intermediate or the precursor) to generate (R)-3-hydroxybutyryl-CoA, although not particularly limited, a gene, a homolog thereof or the like that codes acetoacetyl-CoA reductase (EC number: 1.1.1.36) may be used.
(Gene that Codes (S)-3-Hydroxybutyryl-CoA Selective Enoyl-CoA Hydratase or Gene that Codes (R)-3-Hydroxybutyryl-CoA Selective Enoyl-CoA Hydratase)
In this specification, a “gene that codes (S)-3-hydroxybutyryl-CoA selective enoyl-CoA hydratase” means a gene that codes an enzyme capable of catalyzing a reaction in which (S)-3-hydroxybutyryl-CoA is dehydrated as a substrate (or may be an intermediate or a precursor) to generate crotonyl-CoA. Further, a “gene that codes (R)-3-hydroxybutyryl-CoA selective enoyl-CoA hydratase” means a gene that codes an enzyme capable of catalyzing a reaction in which (R)-3-hydroxybutyryl-CoA is dehydrated as a substrate (or may be an intermediate or a precursor) to generate crotonyl-CoA.
For a specific example of the gene that codes the enzyme capable of catalyzing the reaction in which crotonyl-CoA is generated from (S)-3-hydroxybutyryl-CoA, used in this embodiment, although not particularly limited, a gene or a homolog thereof that codes enoyl-CoA hydratase (EC number: 4.2.1.17) may be used. For the detail of the above mentioned enzyme, a Non-patent document such as “Moskowitz, G. J. and Merrick, J. M., Metabolism of poly-β-hydroxybutyrate. II. Enzymatic synthesis of D-(−)-β-hydroxybutyryl coenzyme A by an enoyl hydrase from Rhodospirillum rubrum, Biochemistry 8 (1969), 2748-2755.” or the like may be referred.
Further, for a specific example of the gene that codes the enzyme capable of catalyzing the reaction in which crotonyl-CoA is generated from (R)-3-hydroxybutyryl-CoA, used in this embodiment, although not particularly limited, a gene, a homolog thereof or the like that codes enoyl-CoA hydratase (EC number: 4.2.1.55 (3-hydroxybutyryl-CoA dehydratase) or EC number: 4.2.1.119) may be used. For the detail of the above mentioned enzyme, Non-patent documents such as “Fukui, T., Shiomi, N. and Doi, Y., Expression and characterization of (R)-specific enoyl coenzyme A hydratase involved in polyhydroxyalkanoate biosynthesis by Aeromonas caviae, J. Bacteriol. 180 (1998), 667-673.”, “Moskowitz, G. J. and Merrick, J. M., Metabolism of poly-p-hydroxybutyrate. II. Enzymatic synthesis of D-(−)-β-hydroxybutyryl coenzyme A by an enoyl hydrase from Rhodospirillum rubrum, Journal Biochemistry 8 (1969), 2748-2755.” or the like may be referred.
(Gene that Codes Vinylacetyl-CoA Delta-Isomerase)
In this embodiment, a gene that codes vinylacetyl-CoA delta-isomerase is not particularly limited as long as it is a gene that codes an enzyme capable of catalyzing a reaction in which vinylacetyl-CoA is generated by transitioning olefin of crotonyl-CoA.
For a specific example of the enzyme capable of catalyzing the above mentioned reaction, although not limited, vinylacetyl-CoA delta-isomerase (EC number: 5.3.3.3), a homolog thereof or the like may be used. For the detail of the above mentioned enzyme, for example, a Non-patent document such as “Fermentation of 4-aminobutyrate by Clostridium aminobutyricum: cloning of two genes involved in the formation and dehydration of 4-hydroxybutyryl-CoA, Archives of Microbiology, 174(3) 189-199 (2000).” or the like may be referred.
(Gene that Codes 4-Hydroxybutyryl-CoA Dehydratase)
In this embodiment, a gene that codes 4-hydroxybutyryl-CoA dehydratase is not particularly limited as long as it is a gene that codes an enzyme that catalyzes a reaction in which vinylacetyl-CoA is hydrated to generate 4-hydroxybutyryl-CoA.
For a specific example of the above mentioned enzyme capable of catalyzing the reaction, although not limited, 4-hydroxybutyryl-CoA dehydratase (EC number: 4.2.1.120), a homolog thereof or the like may be used. For the detail of the above described enzyme, for example, a Non-patent document such as “Fermentation of 4-aminobutyrate by Clostridium aminobutyricum: cloning of two genes involved in the formation and dehydration of 4-hydroxybutyryl-CoA, Archives of Microbiology, 174(3) 189-199 (2000).” or the like may be referred. Here, an example in this Non-patent document relates to a multienzyme of 4-hydroxybutyryl-CoA dehydratase and the above described vinylacetyl-CoA delta-isomerase (EC number: 5.3.3.3) and a gene that codes thereof. However, as long as functions of each enzyme can be appropriately provided, each enzyme or an individual gene that codes a catalytic subunit protein may be used.
(Gene that Codes Acyl-CoA Reductase)
In this embodiment, a gene that codes acyl-CoA reductase is not particularly limited as long as it codes an enzyme capable of catalyzing a reaction in which 4-hydroxybutyryl-CoA is reduced and 4-hydroxybutanal is generated.
For a specific example of the above described enzyme capable of catalyzing the reaction, although not limited, aldehyde dehydrogenase (acylation) (EC number: 1.2.1.10) or a homolog thereof may be used. Here, although the obtained 4-hydroxybutanal is led to 1,4-butanediol by alcohol reductase that is normally possessed by the host, which will be explained later, a gene that codes alcohol reductase may be additionally expressed to manufacture 1,4-butanediol.
Introduction of a gene to a host microbe may be performed by appropriately combining various known methods, for example, such as a method based on restriction enzyme/ligation, an In-Fusion cloning method or the like, such that the above described gene or its part is connected to an appropriate vector and the obtained recombinant vector is introduced into the host so that a purposed gene can be expressed. Alternatively, introduction of a gene to a host microbe may be performed by inserting a target gene or its part at an arbitrary site of a genome by a homologous recombination. “Part” indicates a part of each gene capable of expressing a protein coded by the respective gene when being introduced into the host. In this invention, a gene includes DNA and RNA, and is preferably DNA.
For a vector that connects the gene, it is not particularly limited as long as it is duplicable by a host, and for example, a plasmid, a phage, a cosmid or the like that is used for transgenesis in an Escherichia coli may be used. For a plasmid, for example, pHSG398, pUC18, pBR322, pSC101, pUC19, pUC118, pUC119, pACYC117, pBluescript II SK(+), pETl7b, pETDuet-1, pACYCDuet-1, pCDFDuet-1, pRSFDuet-1, pCOLADuet-1 or the like may be used. For a phage, for example, λgt10, Charon 4A, EMBL-, M13mp18, M13mp19 or the like may be used. Some of them are commercially available and a commercial item (kit) may be used as it is in accordance with its procedures manual, or after appropriately altering.
In the above described vector, an appropriate expression promoter may be connected at upstream of a gene such that the inserted gene is surely expressed. The expression promoter to be used is not particularly limited and is appropriately selected by a person skilled in the art in accordance with the host. For example, T7promoter, lacpromoter, trppromoter, trcpromoter or A-PLpromoter that is used for expressing a foreign gene in Escherichia coli, a Nar promoter region of nitrate reductase gene narGHJI operon that relates to nitrate respiration derived from Escherichia coli, or a promoter region of Frd gene that is nitrate reductase gene of Escherichia coli may be used.
Further, for some cases, it is preferable that the original gene of the host microbe is disrupted so that the gene is not expressed. For a method of disrupting the gene, known methods that are used for disrupting a gene in Escherichia coli may be used. Specifically, a method that is used for manufacturing a knockout cell or the like in this technical field such as a method of disrupting a gene (gene targeting method) using a vector (targeting vector) that generates a homologous recombination at an arbitrary position of a target gene, a method (gene trapping method) in which a trap vector (reporter gene that does not have promoter) is inserted at an arbitrary position of a target gene to disrupt the gene and deactivate its function, a method of combination thereof or the like may be used.
The position at which the homologous recombination is generated or the position to which the trap vector is inserted is not particularly limited as long as it is a position at which modification to deactivate the expression of the target gene to be disrupted, but preferably, is a transcriptional control region.
Further, for a method of introducing the vector to the host, although not particularly limited, for example, a method of using calcium ion, a protoplast method, an electroporation method or the like that is generally used for introducing a vector to Escherichia coli may be used.
A method of inserting a target gene to an arbitrary position on a genome by homologous recombination may be performed by inserting the target gene to a homogenous sequence of a sequence on the genome with a promoter and introducing the nucleic acid fragment to a cell by electroporation to generate homologous recombination. When introducing to the genome, a stock may be selected by which homologous recombination easily occurred when using a nucleic acid fragment to which the target gene and a drug-resistant gene are connected. Further, the target gene may be introduced by homologous recombination by inserting a gene to which a drug-resistant gene and a gene that becomes fatal under a specific condition are connected to the genome by the above described method by homologous recombination, and thereafter, substituting the drug-resistant gene and the gene that becomes fatal under a specific condition.
Further, for a method of selecting a recombinant microbe in which the target gene is introduced, although not particularly limited, it is preferably to use a method by which only a recombinant microbe in which the target gene is introduced can be easily selected.
The present inventors have found that the productivity of 1,4-butanediol is significantly improved by using a gene that codes a specific kind of enzyme in a gene that codes (S)-3-hydroxybutyryl-CoA selective acetoacetyl-CoA reductase and a gene that codes (S)-3-hydroxybutyryl-CoA selective enoyl-CoA hydratase.
Specifically, in order to express a gene that codes (S)-3-hydroxybutyryl-CoA selective acetoacetyl-CoA reductase (3-hydroxybutyryl-CoA dehydrogenase (EC number: 1.1.1.35) or 3-hydroxyacyl CoA dehydrogenase (EC number: 1.1.1.157)), a microbe or a culture thereof is used in which a gene that codes enoyl-CoA hydratase (EC number: 4.2.1.17) is expressed as well.
Further, in order to express a gene that codes (R)-3-hydroxybutyryl-CoA selective acetoacetyl-CoA reductase (EC number: 1.1.1.36), a microbe or a culture thereof is used in which a gene that codes enoyl-CoA hydratase (EC number: 4.2.1.119) or 3-hydroxybutyryl-CoA dehydratase (EC number: 4.2.1.55) is expressed as well.
Further, in the method of manufacturing 1,4-butanediol of the embodiment, it is preferable that a microbe or a culture thereof is used in which a gene that codes vinylacetyl-CoA delta-isomerase (EC number: 5.3.3.3), a gene that codes 4-hydroxybutyryl-CoA dehydratase (EC number: 4.2.1.120) and/or a gene that codes acyl-CoA reductase (EC number: 1.2.1.10) is expressed as well, in addition to the microbe in which the above described genes are expressed by means of transformation or the like. It is preferable to combine all of or a part of these genes, as the productivity of 1,4-butanediol is further improved.
As such, as the method of manufacturing 1,4-butanediol of the embodiment uses a gene that codes a specific enzyme, 1,4-butanediol can be manufactured with high productivity.
Here, in this embodiment, a method of supplying acetoacetyl-CoA that is a substrate of acetoacetyl-CoA reductase and provides 3-hydroxybutyryl-CoA is not particularly limited. For example, a method or the like may be used in which acetyl-CoA that is derived from and supplied from an arbitrary carbon source used for culturing such as sugar such as glucose by a glycolysis system possessed by a host, which will be explained later. At this time, under a condition in which acetyl-CoA is supplied, acetoacetyl-CoA can be supplied using a gene or a homolog thereof that codes β-ketothiolase (EC number: 2.3.1.9) by which one molecule of CoA is desorbed from two molecules of acetyl-CoA to supply acetoacetyl-CoA.
Alternatively, acetoacetyl-CoA may be supplied using a gene or a homolog thereof that codes acetoacetyl-CoA synthase (EC number: 2.3.1.194) that catalyzes a reaction that irreversibly produces acetoacetyl-CoA using acetyl-CoA and malonyl-CoA as substrates (or may be an intermediate or a precursor). For the detail of the acetoacetyl-CoA synthase, for example, a Non-patent document such as “Unprecedented acetoacetyl-coenzyme A synthesizing enzyme of the thiolase superfamily involved in the mevalonate pathway, Proc. Natl. Acad. Sci., U.S.A. 107, 11265-11270 (2010)” or the like may be referred to.
A homolog referred to in the embodiment includes an ortholog and a paralog. An ortholog refers to a set of corresponding genes among species generated from a gene of a common ancestor by means of speciation and enzymes obtained from such genes. A paralog refers to a set of corresponding genes among species generated by means of not speciation but gene duplication in an identical species and enzymes obtained from such genes. A homolog refers to genes that have an identity in sequences thereof, regardless of an ortholog or a paralog, and enzymes obtained from such genes.
More specifically, a homolog (gene) in this embodiment is a gene that has a base sequence with an identity greater than or equal to 90%, preferably an identity greater than or equal to 95%, and more preferably, a gene that is completely identical to such a gene or wherein one or several bases thereof are deleted, substituted, or added.
Furthermore, a homolog gene includes a gene that hybridizes with a gene that has a base sequence complementary with a target gene on a stringent condition. Specifically, it is possible to acquire a gene or an enzyme that is obtained by transformation caused by such a gene, by applying a homology retrieval program (for example, BLAST or FASTA) to a publicly-known data base, or based on an ordinary method such as hybridization, polymerase chain reaction (PCR) or the like under a stringent condition that uses a probe that is composed of at least a part of an identified gene (DNA that is composed of a base sequence complementary with DNA that is composed of a base sequence of such a gene). Furthermore, it is possible for a person skilled in the art to execute self-design by substituting a base sequence or the like. Here, for a stringent condition referred herein, for example, a condition for executing hybridization as described in a Non-patent document of “Molecular Cloning—A LABORATORY MANUAL THIRD EDITION (Joseph Sambrook, David W. Russell. Cold Spring Harbor Laboratory Press)”. Specifically, a hybridizing condition is to be retained with a probe in a solution that includes 6×SSC (a composition of 1×SSC: 0.15 M of sodium chloride, 0.015 M of sodium citrate, pH: 7.0), 0.5% of SDS, 5×Denhardt's solution and 100 mg/mL of herring sperm DNA, at a constant temperature of 65° C. for 8-16 hours.
For example, a reaction in the present invention is most conveniently achieved in such a manner, that a transformed body is cultured in a nutritive medium such as an LB medium at a temperature of 15° C.-40° C., desirably 18° C.-37° C. for about 24 hours, subsequently implanted to a medium with a normal carbon source, for example, a carbon source that is 0.01-50%, desirably 0.1-30%, of glucose, and continuously cultured at a similar temperature for about 1 hour-200 hours, wherein 1,4-butanediol is stored in a culture solution in such a process. Furthermore, a carbon source may be added continuously or intermittently depending on consumption of a carbon source that is caused by proliferation of a bacteria or proceeding of a reaction, and in such a case, a concentration of a carbon source in a reaction fluid is not limited to one described previously.
For a medium carbon source for culturing a microbe, it is possible to use, for example, a saccharide such as glucose, sucrose, fructose or the like, a polyol such as glycerol or the like, an organic substance such as ethanol, acetic acid, citric acid, succinic acid, lactic acid, benzoic acid, fatty acid or the like, or an alkali metal salt thereof, an aliphatic hydrocarbon such as n-paraffin or the like, an aromatic hydrocarbon or a natural organic substance such as peptone, meat extract, fish extract, soybean flour, bran or the like, for example, singly or in combination thereof, at a concentration of normally 0.01%-30%, desirably about 0.1%-20%.
For a medium nitrogen source for culturing a microbe, it is possible to use, for example, an inorganic nitrogen compound such as ammonium sulfate, ammonium phosphate, sodium nitrate, potassium nitrate or the like, a nitrogen-containing organic substance such as urea, uric acid or the like, or a natural organic substance such as peptone, meat extract, fish extract, soybean flour or the like, singly or in combination thereof, at a concentration of normally 0.01%-20%, desirably about 0.1%-100.
Moreover, it is possible to add a phosphate such as potassium dihydrogen phosphate or the like, or a metal salt such as magnesium sulfate, ferrous sulfate, calcium acetate, manganese chloride, copper sulfate, zinc sulfate, cobalt sulfate, nickel sulfate or the like, in accordance with necessity, for growth of a bacteria or improvement of an enzyme activity. A concentration for addition thereof is different depending on a culturing condition, and normally, is 0.01%-5% for a phosphate, 10 ppm-1% for a magnesium salt, or about 0.1 ppm-1,000 ppm for other compounds. Furthermore, for a source of supply for a vitamin, an amino acid, a nucleic acid or the like, it is possible to add, for example, about 1 ppm-100 ppm of yeast extract, casamino acid, or a yeast nucleic acid, depending on a selected medium, for growth of a bacteria or improvement of an enzyme activity.
It is desirable to adjust a pH of a medium to 4.5-9, desirably 5-8. Furthermore, in order to reduce an impurity in a reaction fluid and simplify subsequent fractionation of a product, it is useful to fractionate a bacterial body that is preliminarily cultured in a medium as described previously from a culture solution by a method such as centrifugation or membrane filtration, and again suspend and react in water that includes a reaction raw material, physiological saline, a buffer that has a pH adjusted to be comparable to a pH for culturing and composed of phosphoric acid, acetic acid, boric acid, tris(hydroxymethyl)aminomethane or the like and a salt thereof, or the like. Although a pH during a reaction is able to be normally retained in a case where a buffer with a sufficient concentration is used, it is desirable to be adjusted appropriately by using sodium hydroxide, ammonia or the like so as to provide a similar pH in a case where deviation from a pH as described above is caused by proceeding of a reaction.
When a reaction rate is lowered due to 1,4-butanediol stored in a reaction fluid, a method is preferable that adds water, physiological saline, a reaction buffer or the like, into a reaction fluid depending on a concentration of a product to execute continuous dilution thereof. Furthermore, at a point of time when a reaction rate is lowered, a bacteria is fractionated and a supernatant is recovered as a product solution, wherein a fractionated bacteria is again returned to a solution or suspension that includes a reaction raw material and thereby it is possible to recover a reaction rate. It is possible to execute such an operation continuously or even batch-wise by using a centrifuge, a separation film or the like.
It is possible to execute separation, recovery and purification of 1,4-butanediol produced in a reaction fluid, at a point of time when an amount of produced 1,4-butanediol reaches a substantial amount, by using a general means of separation, recovery, and purification of an organic compound, after a bacterial body is eliminated from such a reaction fluid by means of centrifugation or for such a reaction fluid directly. For example, extraction from a filtrate wherein a bacterial body and the others are eliminated from a culture solution is executed by using an appropriate organic solvent. Such an extract is directly distilled away, is further extracted again with an appropriate solvent, purified by using silica gel chromatography or the like, is subjected to multistage distillation or the like, and thereby, 1,4-butanediol is obtained at a high purity.
The present invention is further explained in detail by explaining examples.
Table 1 illustrates assumed reaction processes, enzymes that catalyze the respective reaction processes, and used genes that code the respective enzymes. Here, the sequence number illustrated for each of the genes corresponds to the sequence number in a sequence listing.
A blunt end fragment was prepared by an ordinary method in which sequences corresponding to 15 base pairs at an upstream side and at a downstream side including upstream side CAT and downstream side ATG of an NdeI site in multi-cloning sites of an expression vector pET17b (produced by Novagen, Inc.), respectively, were added to an upstream and a downstream, at a 5′-end side and a 3′-end side, of a gene sequence indicated by sequence number 1. Ligation of the fragment and a fragment obtained by performing an NdeI process on pET17b (produced by Novagen, Inc.) was executed by In-Fusion HD Cloning Kit (produced by TAKARA BIO INC.) to obtain plasmid pETBD1.
A gene sequence indicated by sequence number 2 was inserted into pET17b targeting at an NdeI site by a method similar to that of pETBD1 to obtain plasmid pETBD2 containing sequence 2.
An EcoRI site derived from multi-cloning sites of pET17b that was positioned at a downstream of a termination codon of sequence 1 of pETBD1 was cleaved by an enzyme process to prepare a ring-opened fragment of pETBD1. Next, a fragment was prepared by PCR in which sequences corresponding to upstream side 15 bp and downstream side 15 bp including the EcoRI site of the pETBD1 were added at an upstream and a downstream of a region of the sequence 2 and its upstream region including T7 promoter derived from pET17b of the pETBD2. Ligation of two obtained fragments was executed by an In-Fusion HD Cloning Kit to obtain plasmid pETBD1-2 containing sequences 1 and 2.
Hereinafter, similarly, by targeting sequences further downstream of sequence 2 of pETBD1-2, sequence number 4, 6 and 7 were added in this order to obtain plasmid pETBD1-2-4-6-7. Here, when adding the sequences, opening of plasmid to which sequences were inserted was executed, by cleavage using a restriction enzyme that does not cleave the inserted when an appropriate restriction enzyme site for the restriction enzyme existed on a vector, or by an inverse PCR from a site to be inserted when such a site did not exist. By pETBD1-2-4-6-7, Escherichia coli pETBD1-2-4-6-7/JM109 (DE3) that was transformed from an Escherichia coli JM109 (DE3) stock was obtained.
By a method similar to that of Example 1, Escherichia coli pETBD1-2-5-6-7/JM109 (DE3) that was transformed by plasmid pETBD1-2-5-6-7 in which the gene of sequence 4 of plasmid pETBD1-2-4-6-7 was substituted by a gene indicated by sequence number 5 that codes an enzyme corresponding to the enzyme that catalyzes the process.
By a method similar to that of Example 1, Escherichia coli pETBD1-3-5-6-7/JM109 (DE3) that was transformed by plasmid pETBD1-3-5-6-7 in which the genes of sequences 2 and 4 of plasmid pETBD1-2-4-6-7 were substituted by genes indicated by sequence numbers 3 and 5 that code enzymes corresponding to the enzymes that catalyze each of the processes.
By a method similar to that of Example 1, Escherichia coli pETBD1-3-4-6-7/JM109 (DE3) that was transformed by plasmid pETBD1-3-4-6-7 in which the gene of sequence 5 of plasmid pETBD1-3-5-6-7 was substituted by a gene indicated by the sequence number 4 that codes an enzyme corresponding to the enzyme that catalyzes the process (comparative example 2).
Each of the obtained transformed bodies was aerobically cultured in 5 mL of an LB medium that contained 100 mg/L of ampicillin at 37° C. for 12 hours. 0.1 mL of a culture solution was implanted into 5 mL of an LB medium that contained 1% of glucose, 100 mg/L of ampicillin, and 0.2 mM of IPTG and aerobically cultured at 30° C. for 48 hours. A supernatant of the culture solution was subjected to high performance liquid chromatography (HPLC: column; Shodex SH-1011 (produced by Showa Denko K. K.), column temperature: 60° C., eluent: 25 mM sulfuric acid aqueous solution, flow rate 0.6 mL/min, detection: differential refraction detector). Table 2 illustrates a relationship between genes that compose plasmids of the used transformed body and the amount of 1,4-butanediol generated in a culturing solution.
As is clearly understood from Table 2, according to the present invention, by using a gene that codes β specific kind of enzyme in a gene that codes (S)-3-hydroxybutyryl-CoA selective acetoacetyl-CoA reductase and a gene that codes (S)-3-hydroxybutyryl-CoA selective enoyl-CoA hydratase, 1,4-butanediol can be efficiently manufactured.
The present application is based on and claims the benefit of priority of Japanese Priority Application No. 2012-257881 filed on Nov. 26, 2012, the entire contents of which are hereby incorporated by reference.
| Number | Date | Country | Kind |
|---|---|---|---|
| 2012-257881 | Nov 2012 | JP | national |
| Filing Document | Filing Date | Country | Kind |
|---|---|---|---|
| PCT/JP2013/074828 | 9/13/2013 | WO | 00 |
